Co-Authors
This is a "connection" page, showing publications co-authored by Jason Glanz and Cynthia Campbell.
Connection Strength
1.288
-
The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment. Addiction. 2022 Jul 11.
Score: 0.751
-
Health Plan Disenrollment and Mortality After Initiation of Medications for Opioid Use Disorder. JAMA Psychiatry. 2026 May 01; 83(5):491-498.
Score: 0.244
-
Development and implementation of a prescription opioid registry across diverse health systems. JAMIA Open. 2022 Jul; 5(2):ooac030.
Score: 0.186
-
Burden of all-cause and cause-specific mortality among individuals with medications for treatment of opioid use disorder: A matched cohort study from 4 US health systems, 2012-2021. J Subst Use Addict Treat. 2026 Apr 15; 209967.
Score: 0.061
-
Mortality Among Patients Prescribed Buprenorphine for Opioid Use Disorder After Disenrollment from an Insurance Plan and Healthcare System. J Gen Intern Med. 2022 Jan 26.
Score: 0.045